Best Peptides for Weight Loss

Peptides used or studied for weight loss and fat reduction. Includes FDA-approved semaglutide, tirzepatide, and the research peptide AOD-9604.

Approved Category Routing

Approved entries in the Weight Loss category

Semaglutide
Semaglutide is currently modeled on this site as an approved treatment path for: Type 2 diabetes mellitus; chronic weight management in adults with obesity or overweight with comorbidities. Brand names in the current dataset: Ozempic, Wegovy, Rybelsus.
Tirzepatide
Tirzepatide is currently modeled on this site as an approved treatment path for: Type 2 diabetes mellitus; chronic weight management in adults with obesity or overweight with comorbidities. Brand names in the current dataset: Mounjaro, Zepbound.
Liraglutide
Liraglutide is currently modeled on this site as an approved treatment path for: Type 2 diabetes mellitus (Victoza); chronic weight management in adults with BMI ≥30 or ≥27 with comorbidities (Saxenda). Brand names in the current dataset: Victoza, Saxenda.
Exenatide
Exenatide is currently modeled on this site as an approved treatment path for: Type 2 diabetes mellitus (adjunct to diet and exercise). Brand names in the current dataset: Byetta, Bydureon BCise.
Dulaglutide
Dulaglutide is currently modeled on this site as an approved treatment path for: Type 2 diabetes mellitus; cardiovascular risk reduction in adults with T2D and established CV disease or multiple risk factors. Brand names in the current dataset: Trulicity.
Setmelanotide
Setmelanotide is currently modeled on this site as an approved treatment path for: Chronic weight management in adult and pediatric patients aged 6 years and older with obesity due to POMC, PCSK1, or LEPR deficiency, or Bardet-Biedl syndrome. Brand names in the current dataset: Imcivree.
Validation Note
This block reflects the site's current structured treatment data and internal routing logic. It does not replace checking current labeling, payer rules, or local prescribing conditions.
11
Peptides
8
FDA Approved
2
Human Studies
1
Preclinical

Semaglutide

A
Weight LossFDA Approved

Semaglutide is a GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Ozempic, Rybelsus) and chronic weight management (Wegovy). ...

Evidence AView Details

Tirzepatide

A
Weight LossFDA Approved

Tirzepatide is the first dual GIP and GLP-1 receptor agonist, approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight manageme...

Evidence AView Details

AOD-9604

C
Weight LossNot Approved

AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) originally developed for obesity treatment. It has been explor...

Evidence CView Details

Liraglutide

A
Weight LossFDA Approved

Liraglutide is a GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Victoza) and chronic weight management (Saxenda). It was th...

Evidence AView Details

Retatrutide

B
Weight LossNot Approved

Retatrutide is an investigational triple-hormone receptor agonist developed by Eli Lilly. It simultaneously targets GIP, GLP-1, and glucagon...

Evidence BView Details

Exenatide

A
Weight LossFDA Approved

Exenatide is a GLP-1 receptor agonist and the first incretin mimetic approved by the FDA for type 2 diabetes (Byetta, 2005; Bydureon BCise, ...

Evidence AView Details

Dulaglutide

A
Weight LossFDA Approved

Dulaglutide is a once-weekly GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Trulicity, 2014). It is a fusion protein consis...

Evidence AView Details

Setmelanotide

A
Weight LossFDA Approved

Setmelanotide is the first melanocortin-4 receptor (MC4R) agonist approved by the FDA for chronic weight management in patients with rare ge...

Evidence AView Details

Pramlintide

A
Weight LossNot Approved

Pramlintide is a synthetic analog of human amylin, a pancreatic beta-cell hormone co-secreted with insulin. It was approved by the FDA in 20...

Evidence AView Details

Survodutide

B
Weight LossNot Approved

Survodutide is a dual GLP-1 and glucagon receptor agonist developed by Boehringer Ingelheim. In Phase 3 trials, it demonstrates significant ...

Evidence BView Details

Tesofensine

A
Weight Loss & MetabolismNot Approved

Tesofensine is a triple monoamine reuptake inhibitor (noradrenaline, dopamine, serotonin) originally developed for Parkinson's and Alzheimer...

Evidence AView Details

GLP-1 Support Essentials

Products to help manage common side effects and support nutrition during treatment.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Progress Tracking Tools

Monitor weight, body composition, and nutrition to maximize results.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Weight Loss Peptides: FAQ